Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 53 citing articles:

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu, et al.
Cell (2020) Vol. 181, Iss. 5, pp. 1036-1045.e9
Open Access | Times Cited: 4140
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems
Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen‐Chun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 201
Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
Alexander A. Cohen, Zhi Yang, Priyanthi N.P. Gnanapragasam, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247963-e0247963
Open Access | Times Cited: 59
The Quest for a Truly Universal Influenza Vaccine
Yo Han Jang, Baik Lin Seong
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 67
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
O. A. Vogel, Balaji Manicassamy
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 53
Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
Brianna L. Bullard, Eric A. Weaver
Vaccines (2021) Vol. 9, Iss. 3, pp. 257-257
Open Access | Times Cited: 49
B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat
Jenna J. Guthmiller, Henry A. Utset, Patrick C. Wilson
Viruses (2021) Vol. 13, Iss. 6, pp. 965-965
Open Access | Times Cited: 44
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens
Yen Thi Kim Nguyen, Xueyong Zhu, Julianna Han, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 7
Open Access
Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
Meagan McMahon, Guha Asthagiri Arunkumar, Wen‐Chun Liu, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 50
Protein engineering strategies for rational immunogen design
Timothy M. Caradonna, Aaron G. Schmidt
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk‐Directed Antibody Response
Steven J. Frey, Juan Manuel Carreño, Dominika Bielak, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 13
Open Access | Times Cited: 14
Progress in the Development of Universal Influenza Vaccines
Wenqiang Sun, Tingrong Luo, Wenjun Liu, et al.
Viruses (2020) Vol. 12, Iss. 9, pp. 1033-1033
Open Access | Times Cited: 36
Improving immunological insights into the ferret model of human viral infectious disease
Julius Wong, Daniel Layton, Adam K. Wheatley, et al.
Influenza and Other Respiratory Viruses (2019) Vol. 13, Iss. 6, pp. 535-546
Open Access | Times Cited: 31
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Daniel E Demminger, Lisa Walz, Kristina Dietert, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 5
Open Access | Times Cited: 27
Targeting Antigens for Universal Influenza Vaccine Development
Quyen Thi Nguyen, Young Ki Choi
Viruses (2021) Vol. 13, Iss. 6, pp. 973-973
Open Access | Times Cited: 26
Animal Models Utilized for the Development of Influenza Virus Vaccines
Ericka Kirkpatrick Roubidoux, Stacey Schultz‐Cherry
Vaccines (2021) Vol. 9, Iss. 7, pp. 787-787
Open Access | Times Cited: 24
Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD
Yulei Li, Peipei Liu, Tianjiao Hao, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses
Willemijn Rijnink, Daniel Stadlbauer, Eduard Puente‐Massaguer, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 9
Historical H1N1 Influenza Virus Imprinting Increases Vaccine Protection by Influencing the Activity and Sustained Production of Antibodies Elicited at Vaccination in Ferrets
Magen E. Francis, Mara McNeil, Nicholas Dawe, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 133-133
Open Access | Times Cited: 29
A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage
Dexin Kong, Yanjuan He, Jiaxin Wang, et al.
Emerging Microbes & Infections (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines
Asim Biswas, Alok K. Chakrabarti, Shanta Dutta
International Reviews of Immunology (2019) Vol. 39, Iss. 1, pp. 21-36
Closed Access | Times Cited: 25
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
Irina Isakova–Sivak, Victoria Matyushenko, Tatiana Kotomina, et al.
Vaccines (2019) Vol. 7, Iss. 3, pp. 61-61
Open Access | Times Cited: 24
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model
Wen‐Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 40-40
Open Access | Times Cited: 19
An epitope-enriched immunogen expands responses to a conserved viral site
Timothy M. Caradonna, Larance Ronsard, Ashraf S. Yousif, et al.
Cell Reports (2022) Vol. 41, Iss. 6, pp. 111628-111628
Open Access | Times Cited: 13
Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo
Julia E. Edgar, Stephanie Trezise, Robert M. Anthony, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 44
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top